A trial to assess the benefits and risks of puberty-suppressing hormone treatment in children and young people who question their gender has been commissioned by NHS England. The ‘Pathways trial’, announced on 22 November 2025, will be led by researchers at King’s College London and will involve 226 children and young people aged under 16 … Continue reading NHS England commissions study on effects of puberty blockers